152 related articles for article (PubMed ID: 35667304)
1. Estimation of optimal antiviral stockpile for a novel influenza pandemic.
Kim S; Bin Seo Y; Lee J; Kim YS; Jung E
J Infect Public Health; 2022 Jul; 15(7):720-725. PubMed ID: 35667304
[TBL] [Abstract][Full Text] [Related]
2. Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective.
Carrasco LR; Lee VJ; Chen MI; Matchar DB; Thompson JP; Cook AR
J R Soc Interface; 2011 Sep; 8(62):1307-13. PubMed ID: 21296791
[TBL] [Abstract][Full Text] [Related]
3. Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response.
McVernon J; McCaw JM; Nolan TM
Aust N Z J Public Health; 2010 Apr; 34(2):113-9. PubMed ID: 23331352
[TBL] [Abstract][Full Text] [Related]
4. Can informal social distancing interventions minimize demand for antiviral treatment during a severe pandemic?
Greer AL
BMC Public Health; 2013 Jul; 13():669. PubMed ID: 23866760
[TBL] [Abstract][Full Text] [Related]
5. Are we prepared for the next influenza pandemic? Lessons from modelling different preparedness policies against four pandemic scenarios.
Panovska-Griffiths J; Grieco L; van Leeuwen E; Baguelin M; Pebody R; Utley M
J Theor Biol; 2019 Nov; 481():223-232. PubMed ID: 31059716
[TBL] [Abstract][Full Text] [Related]
6. Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context.
Moss R; McCaw JM; Cheng AC; Hurt AC; McVernon J
BMC Infect Dis; 2016 Oct; 16(1):552. PubMed ID: 27724915
[TBL] [Abstract][Full Text] [Related]
7. Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic influenza.
Dimitrov NB; Goll S; Hupert N; Pourbohloul B; Meyers LA
PLoS One; 2011 Jan; 6(1):e16094. PubMed ID: 21283514
[TBL] [Abstract][Full Text] [Related]
8. Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season.
Meijer A; Lackenby A; Hay A; Zambon M
Euro Surveill; 2007 Apr; 12(4):E3-4. PubMed ID: 17991386
[TBL] [Abstract][Full Text] [Related]
9. Age-prioritized use of antivirals during an influenza pandemic.
Merler S; Ajelli M; Rizzo C
BMC Infect Dis; 2009 Jul; 9():117. PubMed ID: 19638194
[TBL] [Abstract][Full Text] [Related]
10. Using a Dynamic Model to Consider Optimal Antiviral Stockpile Size in the Face of Pandemic Influenza Uncertainty.
Greer AL; Schanzer D
PLoS One; 2013; 8(6):e67253. PubMed ID: 23805303
[TBL] [Abstract][Full Text] [Related]
11. The impact of case diagnosis coverage and diagnosis delays on the effectiveness of antiviral strategies in mitigating pandemic influenza A/H1N1 2009.
Kelso JK; Halder N; Milne GJ
PLoS One; 2010 Nov; 5(11):e13797. PubMed ID: 21072188
[TBL] [Abstract][Full Text] [Related]
12. Antivirals in the management of an influenza pandemic.
Harrod ME; Emery S; Dwyer DE
Med J Aust; 2006 Nov; 185(S10):S58-61. PubMed ID: 17115954
[TBL] [Abstract][Full Text] [Related]
13. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy.
Wu JT; Leung GM; Lipsitch M; Cooper BS; Riley S
PLoS Med; 2009 May; 6(5):e1000085. PubMed ID: 19440354
[TBL] [Abstract][Full Text] [Related]
14. Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs.
McCaw JM; Wood JG; McCaw CT; McVernon J
PLoS One; 2008 Jun; 3(6):e2362. PubMed ID: 18523549
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic.
Khazeni N; Hutton DW; Garber AM; Owens DK
Ann Intern Med; 2009 Dec; 151(12):840-53. PubMed ID: 20008760
[TBL] [Abstract][Full Text] [Related]
16. [The use of antiviral agents during an (impending) influenza pandemic].
Opstelten W; van Steenbergen JE; van Essen GA; Van der Sande MA
Ned Tijdschr Geneeskd; 2007 May; 151(18):1008-12. PubMed ID: 17508684
[TBL] [Abstract][Full Text] [Related]
17. Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.
Prosper O; Saucedo O; Thompson D; Torres-Garcia G; Wang X; Castillo-Chavez C
Math Biosci Eng; 2011 Jan; 8(1):141-70. PubMed ID: 21361405
[TBL] [Abstract][Full Text] [Related]
18. A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness.
Halder N; Kelso JK; Milne GJ
BMC Infect Dis; 2014 May; 14():266. PubMed ID: 24884470
[TBL] [Abstract][Full Text] [Related]
19. Logistics of control for an influenza pandemic.
Arinaminpathy N; McLean AR
Epidemics; 2009 Jun; 1(2):83-8. PubMed ID: 21352754
[TBL] [Abstract][Full Text] [Related]
20. Preparing for pandemic influenza: should hospitals stockpile oseltamivir?
Cinti S; Chenoweth C; Monto AS
Infect Control Hosp Epidemiol; 2005 Nov; 26(11):852-4. PubMed ID: 16320980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
